CSR

CSR Management

Identifying six priority areas based on our corporate philosophy and Codes of Conduct, and contributing to sustainable social development through business activities

ONO PHARMACEUTICAL Codes of Conduct represent the ideal state of a company from a perspective of a high standard of ethics. They also guide us in acting with respect for human rights of all people, complying with laws and regulations, and striving to maintain fair relations with society in every aspect our business activities.
Placing the ONO PHARMACEUTICAL Codes of Conduct at the foundation of our CSR management, we have cross-checked them against the Seven Core Subjects of ISO 26000, and identified Six Priority Areas for the CSR activities that would be expected of us. Based on our Corporate Governance, we have defined the other priority areas as Innovative Pharmaceutical Products, Human Resources and Human Rights, The Environment, Fair Operating Practices, and Society, and we are committed to demonstrating accountability to our stakeholders by disclosing information about our efforts in these areas.
*ISO26000 Comparison Table

CSR Management図


ONO PHARMACEUTICAL Codes of Conduct

  • 1. We will develop safe, high quality and effective drugs that help people have a healthy life, and provide society with them in addition to necessary information.
  • 2. We will act with respect for the human rights of all people in every aspect of our business activities.
  • 3. We will comply with the law in every field of our business activities and strive to maintain fair relationships with society.
  • 4. We will make efforts to conserve the global environment in every field of our business activities.
  • 5. We will strive for highly transparent corporate management and proactively disclose business information.
  • 6. We will seek harmony with society as a corporate citizen.

*ISO26000……

The international standard on social responsibility for organizations, published by the ISO (International Organization for Standardization, based in Geneva) in November 2010


Corporate Governance

We enforce transparency in our corporate management, and thus enhance our corporate value, by not only complying with laws and regulations but also by strengthening our corporate governance systems.


Innovative Pharmaceutical Products

We are working to develop innovative pharmaceutical products by combining our distinctive drug discovery approach with cutting-edge technologies at home and abroad in order to meet advanced therapeutic needs. As well, we are using our global network to accelerate clinical development and product development.


Human Resources and Human Rights

ONO believes that “People make the company,” and actively supports the development of individual abilities and positive action taken without fear of failure. We promote efforts to improve safety and health conditions, and to create a working environment where the company and its employees can live in harmony and individual abilities blossom to their full extent.
We also value a society where human rights are fully respected and seek to establish a company with no discrimination.


The Environment

Keeping in mind our corporate social responsibilities for the environment, we make efforts towards realizing a global environment rich in natural beauty through environmentally sustainable activities in all areas of business operations. We promote environmental efforts, working to understand environmental issues, with the involvement of all our employees.


Fair Operating Practices

We strengthen compliance through the thoroughgoing implementation of employee education based on our Codes of Conduct to establish and maintain sound, fair and transparent relations with medical professionals and trading partners as well as with government and administrative bodies.


Society

We raise our social value by consistently and wholeheartedly pursuing the development of pharmaceuticals that truly benefit patients. We always engage with the community with sincerity and conduct ourselves in harmony with the community as a local corporate citizen.



How to Identify Priority Areas

  • 1. ONO PHARMACEUTICAL Codes of Conduct represent the ideal state of a company from six perspectives based on high ethical standards.
  • 2. We identify the social issues to be considered for CSR management and divide them into those which we are required to address, those for which we should give support, and those for which we can give indirect support.
  • 3. We review those issues and assess the progress in addressing the issues, as well as social demand, to identify any additional issues which we should also address or issues for which we should enhance our efforts.


CSR Promotion Structure

To promote CSR activities, we have the CSR Committee in place, chaired by the Corporate Management Division. The Committee, which mainly consists of managers from various divisions, deliberates and makes decisions on important issues and subjects in the six priority areas for CSR activities. The activities of the Committee are periodically reported to the management.


CSR推進体制
Enlarge

ISO 26000 Comparison Table

ISO26000
Core subjects Issues Related items
Organizational Governance CSR Management
Corporate Governance Structure
Internal Control System
Corporate Governance Code
Risk Management
Business Continuity Plan (BCP)
Human Rights Due diligence Respect for Human Rights
Diversity Promotion Initiatives
Enhancing Cultivation of Employee-friendly Workplaces
Human rights risk situations
Avoidance of complicity
Resolving grievances
Discrimination and vulnerable groups
Civil and political rights
Economic, social and cultural rights
Fundamental principles and rights at work
Labor Practices Employment and employment relationships Human Resources
Respect for Human Rights
Diversity Promotion Initiatives
Enhancing Cultivation of Employee-friendly Workplaces
Conditions of work and social protection
Social dialog
Health and safety at work
Human development and training in the workplace
The Environment Prevention of pollution Environmental Management
Ongoing Environmental Protection Activities
Environmental Efficiency / Environmental Accounting
Sustainable resource use
Climate change mitigation and adaptation
Protection of the environment, biodiversity and restoration of natural habitats
Fair Operating Practices Anti-corruption ONO’s Ethical System
Compliance Promotion Initiatives
CSR Procurement
Responsible political involvement
Fair competition
Promoting social responsibility in the value chain
Respect for property rights
Consumer Issues Fair marketing, factual and unbiased information and fair contractual practices Key Product Profiles
Status of Development Pipeline
Innovative Pharmaceutical Products
(Research, Licensing, Development, Manufacturing, and Marketing)
Protecting consumers’ health and safety
Sustainable consumption
Consumer service, support, and complaint and dispute resolution
Consumer data protection and privacy
Access to essential services
Education and awareness
Community Involvement and Development Community involvement Various Corporate Social Responsibility Activities (Web-Based Information Dissemination, Initiatives for Medical Advancement, Activities to Support the Health of People)
Activities as a Corporate Citizen
Education and culture
Employment creation and skills development
Technology development and access
Wealth and income creation
Health
Social investment